全文获取类型
收费全文 | 8443篇 |
免费 | 397篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 185篇 |
妇产科学 | 145篇 |
基础医学 | 1021篇 |
口腔科学 | 153篇 |
临床医学 | 487篇 |
内科学 | 2128篇 |
皮肤病学 | 337篇 |
神经病学 | 594篇 |
特种医学 | 195篇 |
外科学 | 1719篇 |
综合类 | 24篇 |
一般理论 | 1篇 |
预防医学 | 129篇 |
眼科学 | 105篇 |
药学 | 404篇 |
中国医学 | 22篇 |
肿瘤学 | 1197篇 |
出版年
2023年 | 71篇 |
2022年 | 105篇 |
2021年 | 158篇 |
2020年 | 113篇 |
2019年 | 122篇 |
2018年 | 164篇 |
2017年 | 136篇 |
2016年 | 181篇 |
2015年 | 169篇 |
2014年 | 217篇 |
2013年 | 291篇 |
2012年 | 423篇 |
2011年 | 538篇 |
2010年 | 284篇 |
2009年 | 236篇 |
2008年 | 496篇 |
2007年 | 562篇 |
2006年 | 459篇 |
2005年 | 549篇 |
2004年 | 523篇 |
2003年 | 479篇 |
2002年 | 449篇 |
2001年 | 175篇 |
2000年 | 167篇 |
1999年 | 190篇 |
1998年 | 129篇 |
1997年 | 114篇 |
1996年 | 120篇 |
1995年 | 94篇 |
1994年 | 89篇 |
1993年 | 55篇 |
1992年 | 90篇 |
1991年 | 102篇 |
1990年 | 83篇 |
1989年 | 84篇 |
1988年 | 88篇 |
1987年 | 63篇 |
1986年 | 67篇 |
1985年 | 43篇 |
1984年 | 42篇 |
1983年 | 28篇 |
1982年 | 18篇 |
1981年 | 29篇 |
1980年 | 30篇 |
1979年 | 25篇 |
1978年 | 28篇 |
1977年 | 23篇 |
1975年 | 16篇 |
1973年 | 18篇 |
1971年 | 19篇 |
排序方式: 共有8871条查询结果,搜索用时 15 毫秒
991.
992.
993.
Jones RN Deshpande LM Bell JM Turnidge JD Kohno S Hirakata Y Ono Y Miyazawa Y Kawakama S Inoue M Hirata Y Toleman MA 《Diagnostic microbiology and infectious disease》2004,49(4):289-294
Metallo-beta-lactamases (M beta L) were initially characterized in Japan, usually of the IMP-type, and found in Pseudomonas aeruginosa (PSA), Acinetobacter spp. (ACB), or Serratia marcescens (SM). The number of M beta L types has increased worldwide, but geographic dissemination within Japan has appeared limited. This study compares baseline levels of M beta L resistance from two 22-center studies (1996-1997) to the longitudinal sample (3 sites) of Japanese isolates from the SENTRY Antimicrobial Surveillance Program (1998-2002). All minimal inhibitory concentration results were determined by reference methods. A total of 26.8% PSA, 3.4% ACB, and 3.1% Enterobacteriaceae (enterobacters and SM) with resistance to monitored carbapenems (CARB) (minimal inhibitory concentration, > or =8 microg/mL) were screened for M beta L production by disk approximation tests (EDTA and 2-MPA inhibitors), CARB hydrolysis by enzyme extracts, and selected PCR primers for known M beta L types. All M beta L-positive strains (10) were sequenced to determine enzyme identification. Clonality in each center was determined by automated ribotyping and PFGE. The CARB susceptibility rates in PSA decreased (80.7% to 62.0%) over the monitored interval (1998-2002), but varied by medical center location. Among CARB-resistant isolates, 10.8% were attributed to M beta L strains (1.1% of all PSA tested). M beta L identification showed the following: five PSA (three IMP-1, two IMP-2), four SM (one IMP-1, two IMP-1 + OXA-1, and one IMP-11). Also a single ACB had an IMP-1. Eight of 10 M beta L isolations occurred between 2000 and 2002; four occurred in 2002. BRL42715, an AMP-C inhibitor, confirmed AMP-C-mediated resistance in 87.3% of PSA, and outer membrane protein changes were also discovered by membrane studies. Prior results (22 sites, 1997-1998) showed CARB resistance at 22.4-25.6% and 0.5-0.9% M beta Ls (IMP-1) overall; it was slightly elevated in this SENTRY Program sample. In conclusion, M beta L-producing strains from several species persist in Japan, but represent a distinct minority of all CARB-resistant strains (1998-2002). Although M beta L rates appear generally stable in Japan, continued surveillance for these mechanisms seems to be a prudent practice, because of the mobility of the genetic determinants and the emergence of novel enzyme types, especially among the Enterobacteriaceae. 相似文献
994.
Koji?YoshimuraEmail author Nobufumi?Ueda Kentaro?Ichioka Yoshiyuki?Matsui Akito?Terai Yoichi?Arai 《Supportive care in cancer》2005,13(9):685-690
Objectives We prospectively evaluated the prevalence and predictors of complementary medicine (CAM) use among Japanese patients with urologic cancer 1 year after diagnosis.Patients and methods A total of 349 patients with newly diagnosed urologic cancer answered a self-administered questionnaire on CAM use 1 year after diagnosis. General-health-related quality of life (GHQL) of the patients was also assessed at diagnosis and 1 year after diagnosis using the Medical Outcome Study Short Form-36 (SF-36). The overall prevalence, types of CAM used, and costs of CAM were assessed. The effects of several variables including GHQL at baseline and 1 year after treatment on the prevalence of use of CAM were evaluated.Results A total of 164 respondents (47%) admitted using some type of CAM, of which 73 (45%) had used multiple types. Health food, in particular extract from Agaricus blazei, was the most common type of CAM used. CAM users had significantly lower scores for social function, general health perception, and vitality domains than CAM non-users 1 year after diagnosis. This tendency was more marked in users of multiple types of CAM.Conclusions Health food, including extract from A. blazei, was the most commonly used CAM in Japan. The prevalence of CAM use did not differ between patients with prostate cancer and those with urologic cancer other than prostrate cancer. CAM users, especially those who used multiple types of CAM, had lower GHQL scores than non-users of CAM. 相似文献
995.
PKClambda regulates glucose-induced insulin secretion through modulation of gene expression in pancreatic beta cells 下载免费PDF全文
Hashimoto N Kido Y Uchida T Matsuda T Suzuki K Inoue H Matsumoto M Ogawa W Maeda S Fujihara H Ueta Y Uchiyama Y Akimoto K Ohno S Noda T Kasuga M 《The Journal of clinical investigation》2005,115(1):138-145
Altered regulation of insulin secretion by glucose is characteristic of individuals with type 2 diabetes mellitus, although the mechanisms that underlie this change remain unclear. We have now generated mice that lack the lambda isoform of PKC in pancreatic beta cells (betaPKClambda(-/-) mice) and show that these animals manifest impaired glucose tolerance and hypoinsulinemia. Furthermore, insulin secretion in response to high concentrations of glucose was impaired, whereas the basal rate of insulin release was increased, in islets isolated from betaPKClambda(-/-) mice. Neither the beta cell mass nor the islet insulin content of betaPKClambda(-/-) mice differed from that of control mice, however. The abundance of mRNAs for Glut2 and HNF3beta was reduced in islets of betaPKClambda(-/-) mice, and the expression of genes regulated by HNF3beta was also affected (that of Sur1 and Kir6.2 genes was reduced, whereas that of hexokinase 1 and hexokinase 2 genes was increased). Normalization of HNF3beta expression by infection of islets from betaPKClambda(-/-) mice with an adenoviral vector significantly reversed the defect in glucose-stimulated insulin secretion. These results indicate that PKClambda plays a prominent role in regulation of glucose-induced insulin secretion by modulating the expression of genes important for beta cell function. 相似文献
996.
M Goto M Fujisawa A Yamada T Okabe F Takaku M Sasano K Nishioka 《Annals of the rheumatic diseases》1990,49(3):172-176
Angiotensin converting enzyme (ACE) and interleukin 1 activities were assayed simultaneously in the serum free medium from the unstimulated peripheral blood monocytes from 32 patients with rheumatoid arthritis (RA), 11 patients with osteoarthritis, and 25 normal controls matched for age and sex. Angiotensin converting enzyme activity was raised in most (29/32) patients with RA and interleukin 1 activity (most of which was interleukin 1 beta) was enhanced in 11/32 patients with RA, while monocytes from only two patients with osteoarthritis, but from none of the controls, secreted a small amount of ACE alone in the culture condition. Monocytes from patients with early RA (disease duration less than 3 years) released significantly more ACE and interleukin 1 than those from late stage RA (disease duration greater than or equal to 3 years). 相似文献
997.
Keishi Abe Nobuo Irokawa Haruki Aoyagi Hidetoshi Memezawa Minoru Yasujima Yoichi Otsuka Tetsuo Saito Kaoru Yoshinaga 《American heart journal》1975,89(6):723-730
Plasma renin activity (PRA) was measured in 139 healthy subjects and 200 patients with essential hypertension. There was an obvious relationship between the PRA levels and aging. Elevated PRA values were obtained only in younger subjects under 20 years of age, while the PRA levels were very low only in advanced ages over 60 years.In essential hypertensive subjects, subnormal resting PRA was found in 23.5 per cent, normal PRA in 64.5 per cent, and high PRA in 12 per cent. A marked impairment of renal function and severe retinal changes were observed in the patient with high resting PRA values. On the contrary, hypertensive complications of the kidney and ocular fundi were mild in the patients with low resting PRA values.A reaction of renin secretion was studied in 161 patients with essential hypertension. There were no apparent relationships between the responsiveness of the renin system to intravenous furosemide following upright posture and hypertensive vascular injury. 相似文献
998.
Hamaki T Kami M Momomura S Mineishi S Kusumi E Kanda Y Ueyama J Miyakoshi S Morinaga S Takaue Y Mutou Y 《American journal of hematology》2002,71(3):196-199
A 54-year-old man with chronic myelocytic leukemia in blastic phase received reduced-intensity transplantation (RIST) from an HLA-identical unrelated donor. The preparative regimen consisted of busulfan, fludarabine, and anti-thymocyte globulin. Graft-versus-host disease (GVHD) prophylaxis was cyclosporine alone. Because he had a high risk of relapse, we discontinued cyclosporine on day 37, but he did not develop any signs of acute GVHD. To induce GVHD and augment a graft-versus-leukemia effect, we initiated interferon-alpha therapy on day 80 to a maximum dosage of three million units five times a week. He achieved molecular remission on day 94 followed by the development of extensive chronic GVHD the severity of which paralleled to the dose of interferon-alpha GVHD gradually subsided after discontinuation of interferon-alpha and the patient remains in molecular remission 18 months after transplantation. This case suggests that early withdrawal of cyclosporine and the prophylactic use of interferon-alpha are promising in RIST for high-risk leukemia. 相似文献
999.
1000.
Koichi Handa Tsukasa Mori Hiroaki Tanaka Yoichi Takada Akira Matsunaga Akira Kiyonaga Munehiro Shindo Jun Sasaki Kikuo Arakawa 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1992,6(1):85-90
Summary In a double-blind crossover study of 10 normal healthy subjects, we examined the effects of slow-release nifedipine (nifedipine-SR,
10 mg b.i.d) administration on exercise capacity, hormone levels during exercise, and quality of life (QOL) after a 2-week
treatment. Two exercise tests, a progressive exercise test and a constant work-rate exercise test, were performed. Maximal
oxygen uptake (\.VO2max) and blood lactate concentration were measured during the progressive exercise test and the exercise intensity corresponding
to half lactate threshold (LT), LT, and 4 mmol/l of lactate concentration was determined. Subjects underwent 20 minutes of
constant work-rate exercise at each work load, and blood lactate, plasma epinephrine, plasma norepinephrine, plasma renin
activity, plasma aldosterone, atrial natriuretic peptide, plasma β-endorphin, and met-enkephalin were measured. Taking nifedipine-SR
had no effect on the responses of blood pressure, heart rate, VO2max, maximal work load, and LT compared to taking placebo. Blood lactate, plasma catecholamine, plasma renin activity, aldosterone,
atrial natriuretic peptide, and β-endorphin levels increased during exercise, and there was no difference between nifedipine-SR
and placebo. Met-enkephalin did not increase with either treatment. In the QOL questionnaires, no differences were noted between
the two treatments. These findings suggest nifedipine-SR to be a potentially useful drug in view of the lack of effect on
exercise capacity, hormone release, and QOL. 相似文献